Trial
NCT05227742
Exploratory Study of Low Dose Psilocybin
Early Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Alabama at Birmingham
Collaborators
Diamond Therapeutics Inc.
Condition
Demoralization
Intervention
Psilocybin
Why stopped
Sponsor terminated contract due to insufficient funding.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-11